Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone
marrow (BM) investigation of patients with cytopenia and suspected myelodysplastic …

Myelodysplastic syndromes (MDSs) are a heterogeneous group of hematopoietic stem cell
diseases categorized by dysplasia in one or more hematopoietic cell lineages, as well as …

Definite progress has been made in the exploration of myelodysplastic syndromes (MDS) by
flow cytometry (FCM) since the publication of the World Health Organization 2008 …

Current recommendations for diagnosing myelodysplastic syndromes endorse flow
cytometry as an informative tool. Most flow cytometry protocols focus on the analysis of …

This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic
investigation and evaluation of cytopenias of uncertain origin and suspected …

Background Flow cytometry (FCM) aids the diagnosis and prognostic stratification of patients
with suspected or confirmed myelodysplastic syndrome (MDS). Over the past few years …

The diagnostic work‐up of patients suspected for myelodysplastic syndromes is challenging
and mainly relies on bone marrow morphology and cytogenetics. In this study, we …

Flow cytometric analysis is a recommended tool in the diagnosis of myelodysplastic
syndromes. Current flow cytometric approaches evaluate the (im) mature myelo-/monocytic …

Background Flow cytometry (FCM) is a co‐criterion in myelodysplastic syndromes (MDS)
diagnostics according to the WHO classification. The presented study compared diagnostic …

Myelodysplastic syndromes (MDS) are a challenging group of diseases for clinicians and
researchers, as both disease course and pathobiology are highly heterogeneous. In …